Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-16-048508

Options or other derivatives

  • Chief Medical Officer acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
HUMPHREY RACHEL Chief Medical Officer 2016-01-21 Grant or award · Employee Stock Option (right to buy) +65,000 65,000 D: show line 1 in the form
Loading xslF345X03/doc1.xml…